Picture of H Lundbeck A/S logo

HLUN A H Lundbeck A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Brief: H Lundbeck Raises Its Full-Year Guidance For 2023

Aug 16 (Reuters) - H Lundbeck A/S  HLUNb.CO :
    * LUNDBECK'S REVENUE INCREASED BY 13% (+10% CER) TO DKK 10
BILLION
IN THE FIRST SIX MONTHS OF 2023
    * RAISES ITS FULL-YEAR GUIDANCE FOR 2023
    * NOW EXPECTS REVENUE TO REACH DKK 19.5 TO 20.1 BILLION
    * RAISES ITS FULL-YEAR GUIDANCE FOR 2023.
    * NOW EXPECTS REVENUE TO REACH DKK 19.5 TO 20.1 BILLION
COMPARED
TO PREVIOUSLY DKK 19.4 TO 20.0 BILLION
    * ADJUSTED EBITDA IS NOW EXPECTED TO REACH DKK 5.2 TO 5.6
BILLION
COMPARED TO PREVIOUSLY DKK 5.1 TO 5.5 BILLION
    * GROWTH IS DRIVEN BY STRONG DEMAND OF STRATEGIC BRANDS
WHICH MORE
THAN  OFFSETS CONTINUED EROSION OF MATURE PORTFOLIO
    * FOR H2 EXPECTS  CONTINUED STRONG GROWTH OF THE STRATEGIC
BRANDS
    * MATURE BRANDS ARE EXPECTED TO FACE STRONGER  GENERIC
EROSION IN
SECOND HALF OF 2023
SABRIL IS EXPECTED TO BE  NEGATIVELY IMPACTED BY A POTENTIAL
SUPPLY OUTAGE
    * BRINTELLIX/TRINTELLIX STILL IMPACTED BY LOW GROWTH IN THE
U.S.
AND INCREASED  GENERIC PRESSURE IN BRAZIL
    * IN H1 ABILIFY MAINTENA WAS FAVORABLY IMPACTED BY TIMING OF
SHIPMENTS TO MIDDLE EAST, WHICH IS NOT EXPECTED TO OCCUR IN H2
    * H2 TO BE DAMPENED  VERSUS H1 BY TIMING OF  SHIPMENTS IN H1
TO
COUNTRIES SUCH  AS SAUDI ARABIA AND TAIWAN

Source text for Eikon:  ID:nWkr7n0w1R 
Further company coverage:  HLUNb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on H Lundbeck A/S

See all news